1. Home
  2. UNCY vs JVA Comparison

UNCY vs JVA Comparison

Compare UNCY & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • JVA
  • Stock Information
  • Founded
  • UNCY 2016
  • JVA 1971
  • Country
  • UNCY United States
  • JVA United States
  • Employees
  • UNCY N/A
  • JVA N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • UNCY Health Care
  • JVA Consumer Staples
  • Exchange
  • UNCY Nasdaq
  • JVA Nasdaq
  • Market Cap
  • UNCY 71.8M
  • JVA 19.5M
  • IPO Year
  • UNCY 2021
  • JVA 2005
  • Fundamental
  • Price
  • UNCY $0.64
  • JVA $3.55
  • Analyst Decision
  • UNCY Strong Buy
  • JVA
  • Analyst Count
  • UNCY 3
  • JVA 0
  • Target Price
  • UNCY $5.50
  • JVA N/A
  • AVG Volume (30 Days)
  • UNCY 1.1M
  • JVA 140.6K
  • Earning Date
  • UNCY 05-12-2025
  • JVA 06-16-2025
  • Dividend Yield
  • UNCY N/A
  • JVA N/A
  • EPS Growth
  • UNCY N/A
  • JVA 6252.13
  • EPS
  • UNCY N/A
  • JVA 0.53
  • Revenue
  • UNCY N/A
  • JVA $80,327,181.00
  • Revenue This Year
  • UNCY N/A
  • JVA N/A
  • Revenue Next Year
  • UNCY $1,677.16
  • JVA N/A
  • P/E Ratio
  • UNCY N/A
  • JVA $6.71
  • Revenue Growth
  • UNCY N/A
  • JVA 15.77
  • 52 Week Low
  • UNCY $0.20
  • JVA $1.23
  • 52 Week High
  • UNCY $1.29
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 59.78
  • JVA 45.62
  • Support Level
  • UNCY $0.63
  • JVA $3.15
  • Resistance Level
  • UNCY $0.67
  • JVA $3.78
  • Average True Range (ATR)
  • UNCY 0.04
  • JVA 0.33
  • MACD
  • UNCY 0.01
  • JVA 0.12
  • Stochastic Oscillator
  • UNCY 86.36
  • JVA 77.67

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: